Apollomics Inc.
Clinical-stage biotech developing innovative oncology and combination therapies.
APLM | US
Overview
Corporate Details
- ISIN(s):
- KYG0411D1236
- LEI:
- Country:
- United States of America
- Address:
- 989 EAST HILLSDALE BLVD., 94404 FOSTER CITY
- Website:
- https://www.apollomicsinc.com
- Sector:
- Manufacturing
Description
Apollomics Inc. is a clinical-stage biotechnology company focused on the discovery and development of innovative oncology therapies. The company's approach centers on creating treatments, particularly combination therapies, that can be integrated with other options to inhibit cancer. These therapies are designed to harness the body's immune system and target specific molecular pathways. Apollomics utilizes a science-driven methodology, including in-house research and development and rigorous clinical trials based on sound mechanistic rationale, with the goal of transforming the treatment landscape for patients with difficult-to-treat cancers.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Apollomics Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Apollomics Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Apollomics Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
